Submission Details
| 510(k) Number | K905721 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 21, 1990 |
| Decision Date | February 21, 1991 |
| Days to Decision | 62 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
K905721 is an FDA 510(k) clearance for the OPUS GENTAMICIN, a Fluorescent Immunoassay Gentamicin (Class II — Special Controls, product code LCQ), submitted by Pb Diagnostic Systems, Inc. (Westwood, US). The FDA issued a Cleared decision on February 21, 1991, 62 days after receiving the submission on December 21, 1990. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3450.
| 510(k) Number | K905721 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 21, 1990 |
| Decision Date | February 21, 1991 |
| Days to Decision | 62 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
| Product Code | LCQ — Fluorescent Immunoassay Gentamicin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3450 |